Teleflex: FDA 510(k) clearances across all its applicant names
FDA lists 568 510(k) clearances, 2 PMA and 2 De Novo decisions across the 31 applicant names Caduvo groups under Teleflex, first 1976, latest 2026. Median 510(k) review time across these names: 89 days. Since 2017 the median was 105 days, against 133 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 18 | 99 |
| 2013 | 16 | 85 |
| 2014 | 26 | 130 |
| 2015 | 15 | 190 |
| 2016 | 20 | 133 |
| 2017 | 20 | 103 |
| 2018 | 16 | 88 |
| 2019 | 13 | 140 |
| 2020 | 11 | 99 |
| 2021 | 3 | 81 |
| 2022 | 9 | 209 |
| 2023 | 8 | 62 |
| 2024 | 6 | 132 |
| 2025 | 6 | 116 |
| 2026 | 7 | 97 |
The 31 FDA applicant names in this group
| Applicant name | 510(k) clearances | PMA | De Novo | Years |
|---|---|---|---|---|
| Arrow Intl., Inc. | 110 | 0 | 0 | 1976–2010 |
| Vascular Solutions, Inc. | 104 | 1 | 0 | 2002–2020 |
| Teleflexmedical, Inc. | 64 | 0 | 0 | 1985–2024 |
| Rusch Intl. | 43 | 0 | 0 | 1995–2003 |
| Teleflex Medical | 43 | 0 | 0 | 2003–2026 |
| Hudson Oxygen Therapy Sales Co. | 33 | 0 | 0 | 1976–1990 |
| Rusch, Inc. | 26 | 0 | 0 | 1993–2001 |
| Arrow International, Inc. | 19 | 0 | 0 | 2003–2020 |
| Vidacare Corporation | 19 | 0 | 0 | 2004–2014 |
| Neotract, Inc. | 16 | 0 | 1 | 2006–2023 |
| Hudson Respiratory Care, Inc. | 15 | 0 | 0 | 1990–2003 |
| Teleflex, Inc. | 11 | 0 | 0 | 1986–2025 |
| Vascular Solutions, LLC | 11 | 0 | 0 | 2019–2024 |
| Arrow International, Inc. (Subsidiary of Teleflex, Inc.) | 10 | 0 | 0 | 2013–2018 |
| Z-Medica Corporation | 8 | 0 | 0 | 2005–2013 |
| Arrow International (Subsidiary of Teleflex Inc.) | 6 | 0 | 0 | 2012–2013 |
| Z-Medica, LLC | 5 | 0 | 1 | 2013–2022 |
| Arrow International, LLC (A subsidiary of Teleflex, Inc.) | 4 | 0 | 0 | 2022–2025 |
| Teleflex Medical, LLC | 3 | 1 | 0 | 2026–2026 |
| Arrow International, LLC | 3 | 0 | 0 | 2023–2025 |
| Teleflex Medical Sdn. Bhd. | 3 | 0 | 0 | 2026–2026 |
| Ventronics, Div of Hudson Oxygen Therapy Sales Co. | 2 | 0 | 0 | 1981–1981 |
| Vidacare, LLC | 2 | 0 | 0 | 2014–2014 |
| Arrow International (A Subsidiary of Teleflex, Inc.) | 1 | 0 | 0 | 2015–2015 |
| Arrow International, Inc. (A Subsidiary of Teleflex, Inc.) | 1 | 0 | 0 | 2016–2016 |
| Arrow International, Inc (Subsidiary of Teleflex I | 1 | 0 | 0 | 2014–2014 |
| Arrow International, Inc. (Subsidiary of Telelflex Inc.) | 1 | 0 | 0 | 2017–2017 |
| Arrow International, LLC Subsidiary of Teleflex Incorporated | 1 | 0 | 0 | 2022–2022 |
| Arrow International, Teleflex | 1 | 0 | 0 | 2019–2019 |
| Teleflex Medical Group | 1 | 0 | 0 | 2003–2003 |
| Vascular Solutions Zerusa , Ltd. | 1 | 0 | 0 | 2012–2012 |
Review time against the same product codes
Since 2017, 510(k)s cleared under these names took a median 105 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 133 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DQY | Catheter, Percutaneous | 39 | 39 |
| BTR | Tube, Tracheal (W/Wo Connector) | 25 | 25 |
| DQX | Wire, Guide, Catheter | 23 | 23 |
| DSP | System, Balloon, Intra-Aortic And Control | 23 | 23 |
| FMI | Needle, Hypodermic, Single Lumen | 23 | 23 |
| CAZ | Anesthesia Conduction Kit | 21 | 21 |
| DYB | Introducer, Catheter | 21 | 21 |
| LJS | Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days | 21 | 21 |
| QSX | Hemostatic Wound Dressing With Thrombin Or Other Biologics | 18 | 18 |
| GAT | Suture, Nonabsorbable, Synthetic, Polyethylene | 16 | 16 |
Plus 116 more product codes.
Review panels
- Cardiovascular (169)
- Anesthesiology (138)
- General and Plastic Surgery (99)
- General Hospital (85)
- Gastroenterology and Urology (73)
- Orthopedic (4)
- Ear, Nose and Throat (2)
- Neurology (1)
- Clinical Toxicology (1)
Most recent Teleflex 510(k) clearances
| 510(k) | Device | Applicant name | Product code | Decision date | Review days |
|---|---|---|---|---|---|
| K262531 | OnControl Powered Bone Access Systems;OnControl Bone Marrow Aspiration System;OnControl Bone Marrow Biopsy System;OnControl Bone Lesion Biopsy System;OnControl Power Driver | Teleflex Medical, LLC | KNW | 2026-10-27 | 97 |
| K261418 | Liquick X-treme, Liquick X-treme Plus | Teleflex Medical | EZD | 2026-09-23 | 146 |
| K262056 | Rusch Latex Gold Foley Catheter | Teleflex Medical Sdn. Bhd. | EZL | 2026-08-05 | 48 |
| K261988 | Monodek (POLYDIOXANONE) Dyed Violet Monofilament Synthetic Absorbable Surgical Suture | Teleflex Medical, LLC | NEW | 2026-07-09 | 27 |
| K252643 | Iso-Gard Filter Straight; Humid-Vent Filter Compact Angled | Teleflex Medical Sdn. Bhd. | CAH | 2026-05-15 | 267 |
| K260775 | Polyethylene;Polyethylene Fusion;Polyethylene OrthoTape | Teleflex Medical, LLC | GAT | 2026-05-06 | 57 |
| K252537 | Rusch SoftSimplastic Foley Catheters | Teleflex Medical Sdn. Bhd. | EZL | 2026-01-20 | 161 |
| K251054 | Hem-o-lok PurplePlus Large Polymer Ligating Clips | Teleflex Medical | FZP | 2025-07-03 | 90 |
| K242495 | LMA Fastrach ETT SU | Teleflex Medical | BTR | 2025-04-29 | 250 |
| K250542 | AC3 Range Intra-Aortic Balloon Pump | Arrow International, LLC | DSP | 2025-03-26 | 30 |
558 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P180025 | PMA | MANTA Vascular Closure Device | 2019-02-01 |
| DEN160012 | De Novo | Temporary, Internal Use Hemostatic | 2017-06-30 |
| DEN130023 | De Novo | Implantable Transprostatic Tissue Retractor System | 2013-09-13 |
| P990037 | PMA | VASCULAR SOLUTIONS DUETT SEALING DEVICE | 2000-06-22 |
Recalls
1,063 product recalls in 286 recall events under these names; 104 initiated in the last five years.
134 product recalls in 17 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 106 initiated in the last five years. Most often: TELEFLEX LLC (101), Arrow International, Inc., Division of Teleflex Medical Inc. (12), Boston Scientific Corporation (9).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
ClinicalTrials.gov lists 34 device studies (4 active or recruiting) with an industry lead sponsor under the 5 sponsor names below. Most recent:
- NCT07258290: Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions (Teleflex; Recruiting, started 2026-06-11)
- NCT06779630: Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (Teleflex; Recruiting, started 2025-07-18)
- NCT05784558: RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up (NeoTract, Inc.; Withdrawn, started 2025-01-26)
- NCT06604039: A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices (Teleflex; Recruiting, started 2024-12-08)
- NCT06364865: AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study (Teleflex; Completed, started 2024-06-07)
| Lead sponsor name on ClinicalTrials.gov | Device studies |
|---|---|
| Vidacare Corporation | 10 |
| NeoTract, Inc. | 9 |
| Teleflex | 8 |
| Vascular Solutions LLC | 6 |
| Z-Medica | 1 |
Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.
Parent company SEC filings
TELEFLEX INC (TFX): EDGAR filings, CIK 96943. The parent's SEC registrant is entered by hand for this group, not matched by name.
How this group is built
Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
Weck surgical products (the PILLING WECK and WECK CLOSURE SYSTEMS names are left out because their acquisition history is not confirmed), Rüsch (1989), Hudson RCI (2004), Arrow International (2007), LMA (2012), Vidacare (2013), Vascular Solutions (2017), NeoTract (2017), Z-Medica (2020). Includes filings made before each acquisition.
Sources
Frequently asked questions
How many FDA 510(k) clearances are listed across Teleflex's applicant names?
FDA lists 568 510(k) clearances, 2 PMA and 2 De Novo decisions across the 31 applicant names Caduvo groups under Teleflex, first 1976, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.
Which FDA applicant names does Teleflex file under?
The names with the most 510(k) clearances in this group are Arrow Intl., Inc. (110); Vascular Solutions, Inc. (104); Teleflexmedical, Inc. (64); Rusch Intl. (43); Teleflex Medical (43). The full list of 31 names is on this page.
How long does FDA take to clear Teleflex 510(k)s?
The median time from FDA receipt to decision across 510(k)s cleared under these names is 89 days. Since 2017 the median was 105 days, against 133 days for all cleared 510(k)s in the same product codes.
Does the Teleflex count include acquired companies?
Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.
How many device clinical trials does Teleflex sponsor?
ClinicalTrials.gov lists 34 device studies (4 active or recruiting) with an industry lead sponsor under 5 sponsor names Caduvo groups under Teleflex. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.
Next steps
- See all 568 Teleflex clearances with predicates and recalls
- Run predicate analysis for product code DQY, Teleflex's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.
All parent companies · FDA device companies by applicant name · FDA product code lookup